Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 0 | 0 | 0 | 0 | 185 |
Cost of Goods | N/A | N/A | N/A | N/A | 40 |
Gross Profit | N/A | N/A | N/A | N/A | 145 |
Operating Expenses | 1,185 | 2,553 | 1,313 | -739 | 2,414 |
Operating Income | -1,185 | -2,553 | -1,313 | 466 | -2,229 |
Interest Expense | 431 | 447 | 313 | 321 | 332 |
Other Income | 4 | 12 | 10 | 25 | 133 |
Pre-tax Income | -1,612 | -2,988 | -1,616 | 170 | -2,428 |
Net Income Continuous | -1,612 | -2,988 | -1,616 | 170 | -2,428 |
Net Income Discontinuous | -452 | -806 | -814 | N/A | N/A |
Net Income | $-2,064 | $-3,794 | $-2,430 | $-2,906 | $-2,428 |
EPS Basic Total Ops | -812.50 | -1,512.50 | -975.00 | -1,100.00 | -1,000.00 |
EPS Basic Continuous Ops | -637.50 | -1,187.50 | -650.00 | 98.53 | -980.99 |
EPS Basic Discontinuous Ops | -175.00 | -325.00 | -325.00 | N/A | N/A |
EPS Diluted Total Ops | -812.50 | -1,512.50 | -975.00 | -1,100.00 | -1,000.00 |
EPS Diluted Continuous Ops | -637.50 | -1,187.50 | -650.00 | 98.53 | -980.99 |
EPS Diluted Discontinuous Ops | -175.00 | -325.00 | -325.00 | N/A | N/A |
EBITDA(a) | $-849 | $-2,190 | $-1,071 | $1,097 | $-1,983 |